Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...

Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...

Miami-based eMed, which focuses on health management for the GLP-1 and GIP population, said Yaccarino’s experience will be ...

Just a month after her exit from Musk's X, the tech executive will lead the digital platform for GLP-1 health management ...

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social ...

The choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative ...

The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.

eMed’s Urgent Care Telehealth Kits offer telehealth-guided, symptom-based exams and evaluations by licensed clinicians via telehealth; and, if necessary, access to prescription medication.